Statin Audit

1,110 views
995 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,110
On SlideShare
0
From Embeds
0
Number of Embeds
25
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • This was a meta analysis in the JAMA that showed that statin use was not associated with an increased risk of cancer.
  • Statin Audit

    1. 1. Audit: use of statins for the primary prevention of CVD<br />Jim Hare and Charles Read<br />
    2. 2.
    3. 3.
    4. 4.
    5. 5.
    6. 6.
    7. 7.
    8. 8.
    9. 9. Methods<br />Search strategy<br />Everyone on a statin<br />Aged 40-75<br />Excluding diabetics, familial hypercholesterolaemia<br />Excluding those with existing CVD<br />This returned 654 patients. We took a random sample of 10%<br />
    10. 10. Assessment of CVD RiSK<br />
    11. 11. Results<br />12/65 (18%) were not eligible<br />35/53 (66%) had a 10-year CVD risk of &lt;20%<br />14/53 (26%) had a 10-year CVD risk of &lt;20% but &gt;15%<br />12/53 (23%) had a 10-year CVD risk of &lt;10%<br />Smoking status was often difficult to determine <br />
    12. 12. Take home messages<br />Statins are good but...<br />They have their side effects<br />NNT=170 for four years<br />In those without CVD, only start a statin if the 10-year risk is &gt;20%<br />Use an established calculator<br />Record your reasoning in the notes (making reference to all risk factors)<br />

    ×